News
L Catterton backs beauty industry biotech supplier
L Catterton has led a CNY 200m (USD 27m) Series B round for Trautec, a China-based biotech start-up that develops synthetic proteins used in beauty and healthcare products.
AVCJ daily bulletin returns October 3
AVCJ's daily bulletin will not be published on October 2 due to the public holiday in Hong Kong.
China's Enflame secures $273m Series D
Shanghai International Group (SIG) – acting through an assortment of investment units – has led a CNY 2bn (USD 273m) Series D round for Chinese artificial intelligence (AI) chip designer Enflame Technology.
LPs favour co-invest, secondaries as allocation appetite warms - survey
LPs are more willing to allocate to private markets strategies compared to a year ago, although co-investment and secondaries are prioritized over buyout and venture, according to a global survey by Goldman Sachs Asset Management (GSAM).
Bain pursues $147m acquisition of Japan's System Information
Bain Capital has agreed to acquire Tokyo-listed Systems Information (SI&C) via a tender offer that values the software and IT provider at about JPY 22bn (USD 147m).
Australia SaaS platform Neara upsizes Series B
Australia’s Neara, a software-as-a-service (SaaS) platform that helps power companies simulate natural disaster scenarios, has closed a USD 24m Series B round featuring Prosus Ventures.
DCM adds partners in Japan, China
DCM has promoted two Asia-based investment professionals – Kenichiro Hara and Fiona Huang, who focus on Japan and China, respectively – to partner.
China healthcare AI start-up Huimei gets $41m Series D
Eastern Bell Capital has led a Series D round of more than CNY 300m (USD 41m) for Huimei Cloud Technology, a China-based provider of artificial intelligence-enabled (AI) software that helps doctors make clinical decisions.
Vertex leads $20m round for India D2C beauty player
Vertex Ventures Southeast Asia and India (VVSEAI), an affiliate of Temasek Holdings-owned Vertex Holdings, has led a USD 20m Series B round for Indian D2C beauty and personal care brand Pilgrim.
China GP Tiantu Capital targets $253m Hong Kong IPO
Chinese consumer-focused venture capital firm Tiantu Capital has launched a Hong Kong IPO with a view to raising as much as HKD 1.9bn (USD 253m).
PAG to buy cinema business from Chinese property developer
PAG has agreed to acquire Shanghai Xingyi Cinema Management from Hong Kong-listed property developer Seazen for about CNY 1.4bn (USD 187m).
Alibaba confirms Hong Kong IPO plan for logistics unit
Alibaba Group’s logistics unit has filed for an IPO in Hong Kong, potentially creating liquidity events for private equity backers such as Yunfeng Capital, Primavera Capital Group, and Princeville Global, as well as for GIC, Temasek Holdings, and Khazanah...
Novo Tellus hits $375m first close on third Indo-Pacific fund
Novo Tellus Capital Partners, an investor in industrial technology assets across the Indo-Pacific region, has reached a first close of approximately USD 375m on its third fund – matching the overall target for the vehicle.
Matrix, HongShan back China's Qihan Biotech
Matrix Partners China and HongShan (formerly Sequioa Capital China) have joined a USD 16m pre-Series B round for Qihan Biotech, a genome editing player active in human and agricultural therapies.
Trifecta closes third India venture debt fund on $214m
Trifecta Capital has closed its third India venture debt fund with about INR 17.8bn (USD 214) in commitments. The initial target was INR 10bn with a greenshoe option of INR 5bn.
ShawKwei commits $34m to US EV battery manufacturer
Asia-focused industrial technology investor ShawKwei & Partners has announced its third investment in a US-based company in three weeks, with a USD 34.3m commitment to battery manufacturer Group14 Technologies.
Indian regulator approves Blackstone's purchase of Care Hospitals
The Blackstone Group’s proposed acquisition of India-based hospital chain Care Hospitals from TPG’s The Rise Fund has won approval from the national competition regulator.
China's Lynk Pharmaceutical increases Series C to $44m
China-based drug developer Lynk Pharmaceuticals has closed a second tranche of Series C funding, taking the overall size of the round to CNY 322m (USD 44m).
KKR-owned Kokusai Electric targets $749m Tokyo IPO
KKR is eyeing a partial exit from Kokusai Electric after the Japan-based semiconductor industry supplier announced plans to raise JPY 111.2bn (USD 749m) through a Tokyo IPO.
India livestreaming platform Eloelo raises $22m
US investors Courtside Ventures and Griffin Gaming Partners have led a USD 22m pre-Series B round for Indian social gaming and livestreaming platform Eloelo.
Paine Schwartz to buy Australia's Costa Group
Paine Schwartz Partners has reached an agreement to acquire Australian fresh fruit and vegetables supplier Costa Group for an enterprise value of approximately AUD 2.46bn (USD 1.58bn).
GGV to spin off Asia operation
GGV Capital’s Asia business will sever ties with the firm’s international operation – switching to separate partnerships and a distinct brand – as venture capital continues to feel the impact of the US and China’s conflicting technology agendas.
JIP-led consortium completes Toshiba tender offer
A consortium led by Japan Industrial Partners (JIP) has successfully completed a tender offer for Toshiba Corporation, paving the way for a JPY 2trn (USD 13.6bn) privatisation of the company.
Peak XV, Elevation, Andreessen back India visa platform
Peak XV Partners, formerly Sequoia Capital India, and Elevation Capital have led a USD 12m Series A round for Indian visa platform Atlys with support from Andreessen Horowitz.